Manulife (Manufacturers Life Insurance)’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
Other funds holding OREX
BG
BI
FCMI
NMC
CS
RSCM
OWIM
Manulife (Manufacturers Life Insurance)'s OREX Position: Q3 2017 in Review
Manulife (Manufacturers Life Insurance) sold out of Orexigen Therapeutics, Inc. (OREX) in Q3 2017, closing a stake of 369 shares — an estimated $1K sold.
Manulife (Manufacturers Life Insurance) first reported a position in OREX in Q2 2013 and held it in 16 quarters. The position peaked at $455K in Q2 2014. 42 funds tracked by Wall St. Rank hold OREX as of Q3 2017.
- Manulife (Manufacturers Life Insurance) reported no remaining Orexigen Therapeutics, Inc. position as of Q3 2017 after selling out during the quarter.
- Manulife (Manufacturers Life Insurance) sold 369 Orexigen Therapeutics, Inc. shares in Q3 2017, an estimated $1K.
- Manulife (Manufacturers Life Insurance) first reported a position in Orexigen Therapeutics, Inc. in Q2 2013 and held it in 16 quarters.
- Manulife (Manufacturers Life Insurance)'s Orexigen Therapeutics, Inc. position peaked at $455K in Q2 2014.
- 42 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q3 2017.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2017, filed 14 Nov 2017.